Influence of metabolic syndrome and its components on subclinical organ damage in hypertensive perimenopausal women

Advances in Medical Sciences

Volumn 59, Issue 2, 2014, Pages 232-239

  Olszanecka, Agnieszka ^a   Dragan, Aneta ^b   Kawecka Jaszcz, Kalina ^a   Czarnecka, Danuta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Nowy Sacz Hospital   (Poland)

Author keywords

Hypertension; Menopause; Metabolic syndrome; Organ damage

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; LIPID;

ADULT; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL COMPLIANCE; CARDIOMETABOLIC RISK; CAROTID ARTERY PULSE; CAROTID ATHEROSCLEROSIS; CLIMACTERIUM; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; KIDNEY INJURY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PHYSICAL DISEASE BY BODY FUNCTION; PREDICTIVE VALUE; PULSE WAVE; SUBCLINICAL ORGAN DAMAGE; URINALYSIS;

EID: 84908462058     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2013.12.002     Document Type: Article

References (33)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640-5.
2. Zdrojewski T. Rozpowszechnienie i kontrola nadcis̈nienia te¸tniczego w Polsce - porównanie z wybranymi krajami w Europie i na s̈wiecie. In: Wie¸cek A, Januszewicz A, Szczepańska-Sadowska E, Prejbisz A, editors. Hipertensiologia: patogeneza, diagnostyka i leczenie nadcis̈nienia te¸tniczego. Kraków: Medycyna Praktyczna; 2011. p. 1-5 (in Polish).
3. Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, et al. The metabolic syndrome in hypertension: European society of hypertension position statement. J Hypertens 2008;26(10):1891-900.
4. Cifkova R, Pitha J, Lejskova M, Lanska V, Zecova S. Blood pressure around the menopause: a population study. J Hypertens 2008;26(10):1976-82.
5. Schillaci G, Pirro M, Pucci G, Mannarino MR, Gemelli F, Siepi D, et al. Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension 2006;47(5):881-6.
6. Tsioufis C, Tsiachris D, Dimitriadis K, Chartzoulakis G, Selima M, Chatzis D, et al. Evidence for no global effect of metabolic syndrome per se on early hypertensive sequelae. J Hypertens 2008;26(4):773-9.
7. Navarro J, Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Bonet A, et al. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study. Blood Press 2007;16(1):20-7.
8. Mulè G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005;257(6):503-13.
9. Cuspidi C, Sala C, Lonati L, Negri F, Rescaldani M, Re A, et al. Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: a gender-based study. Blood Press 2013;22(June (3)):138-43.
10. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. JHypertens 2007;25(September (9)):1751-62.
11. Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005;46(August (2)):233-41.
12. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23(January (1)):57-63.
13. Collins AC, Sethi M, MacDonald FA, Brown D, Viberti GC. Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia 1993;36(October (10)):993-7.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18(December (12)):1440-63.
15. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10(March (2)):165-93.
16. Freire CM, Ribeiro AL, Barbosa FB, Nogueira AI, de Almeida MC, Barbosa MM, et al. Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice. Vasc Health Risk Manag 2009;5:811-7.
17. Rajzer MW, Wojciechowska W, Klocek M, Palka I, Brzozowska-Kiszka M, Kawecka-Jaszcz K. Comparison of aortic pulse wave velocity measured by three techniques: Complior, SphygmoCor and Arteriograph. J Hypertens 2008;26(October (10)):2001-7.
18. Lakowska A, Chrostowska M, Szyndler A, ͆miałek K, Szcze¸ch R, Zdrojewski T, et al. Rozpowszechnienie zespołu metabolicznego u chorych z nadcis̈nieniem te¸tniczym w zaleẓnos̈ci od płci. Nadcis̈nienie Te¸tnicze 2005;9:458-62.
19. Mule G, Cottone S, Nardi E, Andronico G, Cerasola G. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage. Minerva Cardioangiol 2006;54(April (2)):173-94.
20. Guerra F, Mancinelli L, Buglioni A, Pierini V, Rappelli A, Dessì-Fulgheri P, et al. Microalbuminuria and left ventricular mass in overweight and obese hypertensive patients: role of the metabolic syndrome. High Blood Press Cardiovasc Prev 2011;118(December (4)):195-201.
21. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004;22(October (10)):1991-8.
22. Sun N, Zhang Y, Tian JL, Wang H. Relationship between uric acid and arterial stiffness in the elderly with metabolic syndrome components. Chin Med J 2013;126(August (16)):3097-102.
23. Chan DT, Watts GF, Irish AB, Ooi EM, Dogra GK. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease. Am J Hypertens 2013;26(September (9)):1155-61.
24. Ferreira I, Boreham CA, Twisk JW, Gallagher AM, Young IS, Murray LJ, et al. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project. J Hypertens 2007;25(May (5)):1009-20.
25. Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B, et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 2006;47(January (1)):72-5.
26. Tentolouris N, Papazafiropoulou A, Moyssakis I, Liatis S, Perrea D, Kostakis M, et al. Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus. Cardiovasc Diabetol 2008;7(January):1.
27. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009;54(December (6)):1328-36.
28. Eguchi K, Schwartz JE, Roman MJ, Devereux RB, Gerin W, Pickering TG. Metabolic syndrome less strongly associated with target organ damage than syndrome components in a healthy, working population. J Clin Hypertens (Greenwich) 2007;9(May (5)):337-44.
29. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004;109(February (6)):706-13.
30. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91(August (8)):2906-12.
31. Flegal KM, Carrol MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288(October (14)):1723-7.
32. El Khoudary SR, Wildman RP, Matthews K, Thurston RC, Bromberger JT, Sutton-Tyrrell K. Progression rates of carotid intima-media thickness and adventitial diameter during the menopausal transition. Menopause 2013;20(January (1)):8-14.
33. Kok HS, van Asselt KM, van der Schouw YT, van der Tweel I, Peeters PH, Wilson PW, et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 2006;47(May (10)):1976-83.